AbSci
  • Our Technology
  • Partnerships
  • About Us
  • Careers
  • News / Updates
  • Contact
  • Facebook
  • Twitter
  • Linkedin
Select Page
AbSci Raises Oversubscribed $12M Series C to Fuel Commercialization of Its Groundbreaking Protein Expression Platform

AbSci Raises Oversubscribed $12M Series C to Fuel Commercialization of Its Groundbreaking Protein Expression Platform

May 29, 2018 | Announcement, Fundraising, News

The Series C Round led by Asahi Glass Co., Ltd. “AGC” includes participation from all prior investors (Phoenix Venture Partners, Oregon Venture Fund, WRF Capital, and Souther Co.) and new investors Columbia Ventures Corporation and GreenBridge.

Sean McClain of AbSci Entrepreneur Of The Year® 2018 Award Finalist in the Pacific Northwest

May 9, 2018 | Announcement, News, Press

EY Announces Sean McClain of AbSci Entrepreneur Of The Year® 2018 Award Finalist in the Pacific Northwest region Vancouver, Washington May 7th, 2018 – EY announced that Founder and CEO Sean McClain of AbSci is a finalist for the Entrepreneur Of The Year® 2018 Award in...
AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board

AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board

Feb 5, 2018 | Announcement, Press

“There’s an electricity of discovery here like Genentech and Amgen,” said Dr. Herman. “AbSci’s ability to fold proteins is an innovative art form. This technology enables more efficient manufacturing, which will bring down the price of drugs.”

AbSci Appoints William F. Bennett, PhD to Scientific Advisory Board

Jan 9, 2018 | Announcement, Press

“The culture here reminds me of Genentech in the early days. It’s an honor to join the team as a Scientific Advisor,” said Dr. Bennett. “AbSci’s technology is a quantum improvement in bacterial expression systems.”

AbSci at 36th JP Morgan Conference January 8th – 11th. 

AbSci at 36th JP Morgan Conference January 8th – 11th. 

Dec 28, 2017 | Announcement

AbSci at 36th JP Morgan Conference January 8th – 11th. The team is fully booked out for the remainder of JPM – Contact Kole Krieger to schedule a phone call – kkrieger@abscibio.com

AbSci Appoints Fred Larimore, PhD to Scientific Advisory Board

Dec 20, 2017 | Announcement, Press

AbSci announced today the appointment of Fred Larimore, PhD to AbSci’s Scientific Advisory Board. Dr. Larimore brings over 30 years of experience in biopharmaceutical manufacturing and process development at leading pharmaceutical companies …

« Older Entries
Next Entries »

Recent Posts

  • AbSci Announces Acquisition of Deep Learning Company Denovium
  • AbSci to Present at the 39th Annual J.P. Morgan Healthcare Conference
  • AbSci Announces Recent Additions to Board of Directors
  • AbSci Announces $65 Million Financing Led by Casdin Capital
  • Alpha Cancer Technologies to License AbSci’s SoluPro Strain for the Expression of Alpha-Fetoprotein

Archives

  • January 2021
  • November 2020
  • October 2020
  • September 2020
  • January 2020
  • July 2019
  • March 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • May 2018
  • February 2018
  • January 2018
  • December 2017
  • October 2017
  • August 2017
  • April 2017
  • January 2017
  • October 2016
  • August 2016
  • May 2016
  • April 2016
  • October 2015
SEE ARCHIVE

Categories

  • Announcement
  • Article
  • Award
  • Fundraising
  • News
  • Press
  • Uncategorized

Designed by Elegant Themes | Powered by WordPress